351 related articles for article (PubMed ID: 16831966)
1. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and impulse control disorders in Parkinson's disease.
Weintraub D
Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
[TBL] [Abstract][Full Text] [Related]
3. Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
Staubo SC; Fuskevåg OM; Toft M; Lie IH; Alvik KMJ; Jostad P; Tingvoll SH; Lilleng H; Rosqvist K; Størset E; Odin P; Dietrichs E; Dietrichs ES
Eur J Neurol; 2024 Feb; 31(2):e16144. PubMed ID: 37955562
[TBL] [Abstract][Full Text] [Related]
4. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.
Toś M; Grażyńska A; Antoniuk S; Siuda J
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758
[No Abstract] [Full Text] [Related]
5. Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period.
Gunduz A; Çiftçi T; Erbil AC; Senoglu G; Ser MH; Apaydın H
Neurol Sci; 2024 Jan; 45(1):171-175. PubMed ID: 37581771
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
[TBL] [Abstract][Full Text] [Related]
7. Impulsive choice and response in dopamine agonist-related impulse control behaviors.
Voon V; Reynolds B; Brezing C; Gallea C; Skaljic M; Ekanayake V; Fernandez H; Potenza MN; Dolan RJ; Hallett M
Psychopharmacology (Berl); 2010 Jan; 207(4):645-59. PubMed ID: 19838863
[TBL] [Abstract][Full Text] [Related]
8. ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
Antonini A; Barone P; Bonuccelli U; Annoni K; Asgharnejad M; Stanzione P
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):317-324. PubMed ID: 28315845
[TBL] [Abstract][Full Text] [Related]
9. Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study.
Almalki MH; Alsuraikh MA; Almalki E; Aziz F; Almazrouei R; AlDahmani KM; Alshahrani F; Alaqeel M; Mahzari M; Ekhzaimy A
Pituitary; 2024 Apr; 27(2):197-203. PubMed ID: 38345719
[TBL] [Abstract][Full Text] [Related]
10. Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?
Toś M; Grażyńska A; Antoniuk S; Siuda J
Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391755
[TBL] [Abstract][Full Text] [Related]
11. What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
Jeon N; Bortolato M
PLoS One; 2020; 15(1):e0227128. PubMed ID: 31910240
[TBL] [Abstract][Full Text] [Related]
12. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.
Claassen DO; Stark AJ; Spears CA; Petersen KJ; van Wouwe NC; Kessler RM; Zald DH; Donahue MJ
Mov Disord; 2017 Nov; 32(11):1574-1583. PubMed ID: 28627133
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced compulsive behaviors: exceptions to the rule.
Graham NA; Hammond CJ; Gold MS
Mayo Clin Proc; 2009 Sep; 84(9):846-7; author reply 847. PubMed ID: 19720785
[No Abstract] [Full Text] [Related]
14. Impulse control disorders in Parkinson's disease: recent advances.
Voon V; Mehta AR; Hallett M
Curr Opin Neurol; 2011 Aug; 24(4):324-30. PubMed ID: 21725242
[TBL] [Abstract][Full Text] [Related]
15. The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease.
Morrow CB; Hinkle JT; Seemiller J; Mills KA; Pontone GM
Am J Geriatr Psychiatry; 2024 Jun; 32(6):710-720. PubMed ID: 38238235
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson's Disease: Lack of Control or Too Much of It?
Kapsomenakis A; Kasselimis D; Vaniotis E; Bougea A; Koros C; Simitsi AM; Stefanis L; Potagas C
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003991
[No Abstract] [Full Text] [Related]
17. Effect of Dopaminergic Therapy on Impulse Control Disorders in Patients With a Prolactinoma.
Ozdeniz Varan E; Gurvit H
Cogn Behav Neurol; 2023 Mar; 36(1):1-8. PubMed ID: 36149404
[TBL] [Abstract][Full Text] [Related]
18. Impulse Control Disorders in Patients with Pituitary Tumors Treated with Dopamine Agonists: A Systematic Review.
Hamblin R; Karavitaki N
Arch Med Res; 2023 Dec; 54(8):102910. PubMed ID: 37985276
[TBL] [Abstract][Full Text] [Related]
19. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease.
Napier TC; Corvol JC; Grace AA; Roitman JD; Rowe J; Voon V; Strafella AP
Mov Disord; 2015 Feb; 30(2):141-9. PubMed ID: 25476402
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of impulse control and related disorders in Chinese Parkinson's disease patients.
Zhang Y; He AQ; Li L; Chen W; Liu ZG
BMC Neurol; 2017 May; 17(1):98. PubMed ID: 28521736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
